SUBLICENSE AGREEMENTSublicense Agreement • March 11th, 2019 • Dermavant Sciences LTD • Pharmaceutical preparations • New York
Contract Type FiledMarch 11th, 2019 Company Industry JurisdictionThis SUBLICENSE AGREEMENT (this “Agreement”) is made and entered into effective as of December 17, 2018 (the “Effective Date”), by and between Dermavant Sciences GmbH, a company organized and existing pursuant to the laws of Switzerland having a principal place of business at Viaduktstrasse 8, Basel 4051, Switzerland (“Sublicensor”) and Roivant Sciences GmbH, a company organized and existing pursuant to the laws of Switzerland having a principal place of business at Viaduktstrasse 8, Basel 4051, Switzerland (“Sublicensee”). Each of Sublicensor and Sublicensee may be referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
SUBLICENSE AGREEMENTSublicense Agreement • March 11th, 2019 • Dermavant Sciences LTD • Pharmaceutical preparations • New York
Contract Type FiledMarch 11th, 2019 Company Industry JurisdictionThis SUBLICENSE AGREEMENT (this “Agreement”) is made and entered into effective as of December 17, 2018 (the “Effective Date”), by and between Dermavant Sciences GmbH, a company organized and existing pursuant to the laws of Switzerland having a principal place of business at Viaduktstrasse 8, Basel 4051, Switzerland (“Sublicensor”) and Roivant Sciences GmbH, a company organized and existing pursuant to the laws of Switzerland having a principal place of business at Viaduktstrasse 8, Basel 4051, Switzerland (“Sublicensee”). Each of Sublicensor and Sublicensee may be referred to in this Agreement individually as a “Party” and collectively as the “Parties.”